Investigators aimed to evaluate and update the Lémann index for the assessment of cumulative bowel damage in patients with Crohn disease.
Due to the relatively high relapse rate and need for additional therapies, current research is being done on the use of Vedolizumab for the treatment of microscopic colitis.
Investigators performed a systematic review to examine the varying definitions of transmural healing and assess its impact on CD-related outcomes.
Researchers compared the effectiveness of the specific carbohydrate diet with the Mediterranean diet for the management of Crohn disease symptoms.
Researchers evaluated perianal involvement in patients with CD and compared disease course in those with severe vs non-severe perianal CD.
Researchers aimed to evaluate the long-term safety and efficacy of ustekinumab in a cohort of patients with Crohn disease with a follow-up of 2 years.
Researchers compared the clinical effectiveness and safety profiles of vedolizumab and anti-TNFα agents in biologic-naïve adult patients with ulcerative colitis and Crohn disease.
The specific carbohydrate diet is not superior to the Mediterranean diet for the remission of symptoms in adults with mild-to-moderate Crohn disease.
In clinical practice guidelines from the American Gastroenterological Association (AGA) published in the June 1 issue of Gastroenterology, recommendations are presented for the management of moderate-to-severe luminal and fistulizing Crohn disease (CD) in adult outpatients.
Researchers evaluated the prevalence and severity of dermatologic inflammatory conditions in patients with IBD.
Investigators analyzed the effects of a novel probiotic supplement on Crohn disease-like ileitis in murine models.
Investigators aimed to identify subpopulations of patients with Crohn Disease in whom vedolizumab had greater success at achieving clinical remission than anti-TNFα.
Researchers studied the interactions between diet, gut microbiota, and their functional ability to induce intestinal inflammation.
Researchers aimed to examine the association of anti-TNF with reduced mortality relative to prolonged corticosteroid use in a cohort of veterans with IBD.
Researchers compared use of a treat-to-target strategy vs standard of care in patients with Crohn disease treated with ustekinumab.
In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.
Researchers sought to validate a MM-SES-CD, which predicts the achievement of ER while on active therapy by taking into consideration each individual parameter’s prognostic value.
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
Researchers aimed to better elucidate the role of fDPP-4 levels as a biomarker of IBD activity and to correlate it with certain clinical parameters.
Diet directly impacts the gut microbiome, which directly affects inflammatory responses in the gut.